Some Melanoma Respond to Immunotherapy Beyond Progression – Cancer Network
|
Some Melanoma Respond to Immunotherapy Beyond Progression
Cancer Network To assess the clinical benefit in patients who continue immunotherapy beyond traditionally defined progression, the investigators conducted a pooled analysis of eight multicenter clinical trials totaling 2,624 patients. All patients had unresectable or … |
